A Meta-ethical Analysis of Moral Discourse on the Jeremy Kyle Show

2013 ◽  
pp. 198-212
Author(s):  
Peter Lunt ◽  
Joseph Livingstone
2021 ◽  
pp. 155-173
Author(s):  
René Balák

Hardly any problem in contemporary theological-moral discourse causes such turbulence as the searching, reflection, and demarcation of the boundaries between good and evil in human acting. A fundamental problem is a criterion or a reference point according to which a person could reliably determine what is good and evil. Divergent theological views in the theological-moral dimension seem to have caused the clear boundaries between good and evil to disappear. Therefore, the crucial question is whether there is still a universal criterion for theological evaluation of a human act, as the situation in theological-moral discourse resembles an areopagus of opinions that have no common point in distinguishing between good and evil. This reflection examines the possibility if the Thomistic ethical analysis of a human act, together with the principle of double effect, may be a reference point for the demarcation of these boundaries.


2013 ◽  
Vol 8 (1) ◽  
pp. 92-109
Author(s):  
Hannah Bacon

Is fat a sin? Popular ‘knowledge’ about obesity which frames fat as an avoidable behavioural condition would certainly suggest it can be blamed on the fat person. Discourses of health reproduced within public policy and media reporting assist in the pathologization of fat bodies, insisting that fat is the result of unhealthy lifestyle choices. It is, however, not simply medical interpretations of fat that facilitate this moral discourse. Religion also provides an important source of moral judgment. This paper draws on my qualitative research inside a UK secular, commercial slimming group to consider how the Christian moral language of sin functions within this setting to construct a politics of choice that holds the dieter personally responsible for her fat. Interpreting weight loss and weight gain as a measure of moral character, this theological language assists in the operation of ‘normative conformity’, conforming women’s bodies to cultural knowledge about fat.


Author(s):  
Derek Parfit

This third volume of this series develops further previous treatment of reasons, normativity, the meaning of moral discourse, and the status of morality. It engages with critics, and shows the way to resolution of their differences. This volume is partly about what it is for things to matter, in the sense that we all have reasons to care about these things. Much of the book discusses three of the main kinds of meta-ethical theory: normative naturalism, quasi-realist expressivism, and non-metaphysical non-naturalism, which this book refers to as non-realist cognitivism. This third theory claims that, if we use the word ‘reality’ in an ontologically weighty sense, irreducibly normative truths have no mysterious or incredible ontological implications. If instead we use ‘reality’ in a wide sense, according to which all truths are truths about reality, this theory claims that some non-empirically discoverable truths — such as logical, mathematical, modal, and some normative truths — raise no difficult ontological questions. This book discusses these theories partly by commenting on the views of some of the contributors to Peter Singer's collection Does Anything Really Matter? Parfit on Objectivity.


Author(s):  
Jacob Busch ◽  
Emilie Kirstine Madsen ◽  
Antoinette Mary Fage-Butler ◽  
Marianne Kjær ◽  
Loni Ledderer

Summary Nudging has been discussed in the context of public health, and ethical issues raised by nudging in public health contexts have been highlighted. In this article, we first identify types of nudging approaches and techniques that have been used in screening programmes, and ethical issues that have been associated with nudging: paternalism, limited autonomy and manipulation. We then identify nudging techniques used in a pamphlet developed for the Danish National Screening Program for Colorectal Cancer. These include framing, default nudge, use of hassle bias, authority nudge and priming. The pamphlet and the very offering of a screening programme can in themselves be considered nudges. Whether nudging strategies are ethically problematic depend on whether they are categorized as educative- or non-educative nudges. Educative nudges seek to affect people’s choice making by engaging their reflective capabilities. Non-educative nudges work by circumventing people’s reflective capabilities. Information materials are, on the face of it, meant to engage citizens’ reflective capacities. Recipients are likely to receive information materials with this expectation, and thus not expect to be affected in other ways. Non-educative nudges may therefore be particularly problematic in the context of information on screening, also as participating in screening does not always benefit the individual.


Author(s):  
Katja Voit ◽  
Cristian Timmermann ◽  
Florian Steger

This paper aims to analyze the ethical challenges in experimental drug use during the early stage of the COVID-19 pandemic, using Germany as a case study. In Germany uniform ethical guidelines were available early on nationwide, which was considered as desirable by other states to reduce uncertainties and convey a message of unity. The purpose of this ethical analysis is to assist the preparation of future guidelines on the use of medicines during public health emergencies. The use of hydroxychloroquine, remdesivir and COVID-19 convalescent plasma in clinical settings was analyzed from the perspective of the ethical principles of beneficence, non-maleficence, justice and autonomy. We observed that drug safety and drug distribution during the pandemic affects all four ethical principles. We therefore recommend to establish ethical guidelines (i) to discuss experimental treatment options with patients from all population groups who are in urgent need, (ii) to facilitate the recording of patient reactions to drugs in off-label use, (iii) to expand inclusion criteria for clinical studies to avoid missing potentially negative effects on excluded groups, and (iv) to maintain sufficient access to repurposed drugs for patients with prior conditions.


Sign in / Sign up

Export Citation Format

Share Document